Reply to: “Amino acid strategy in early postoperative parenteral nutrition” Authors: Yoshikuni Kawaguchi, Kenta Murotani, Nahoki Hayashi, Satoru Kamoshita Published: 2026 We appreciate the thoughtful and insightful comments by Shen et al concerning our recent publication—Association between prescribed parenteral energy doses and the composite of clinical adverse events in adult patients after gastrointestinal cancer surgery: A retrospective cohort study. 1 We agree that, in the early postoperative phase after gastrointestinal cancer surgery, prescribed amino acid doses and the nonprotein energy‐to‐amino acid balance are metabolically and physiologically important. Increased body protein breakdown leads to decreases in body weight, muscle mass, and immune function, 2 , 3 suggesting that prescribed amino acid doses and the nonprotein energy‐to‐amino acid balance may influence clinical outcomes. However, the primary aim of our study was to evaluate the association between prescribed parenteral energy doses and clinical outcomes; therefore, analyses modeling the nonprotein energy‐to‐amino acid balance were beyond the scope of the current study. In this context, we conducted a separate study evaluating the association between the mean prescribed amino acid doses during postoperative days 1 to 7 and a composite of clinical adverse events (in‑hospital mortality, postoperative complications, decline in activities of daily living, or hospital readmission) in patients who exclusively received parenteral nutrition in the early phase after gastrointestinal cancer surgery. 4 We found that higher prescribed amino acid doses were associated with a lower incidence of the composite of clinical adverse events. We divided study patients into the low‐amino acid group (<0.8 g/kg/day) and the high‐amino acid group (≥0.8 g/kg/day) based on the mean prescribed amino acid doses during postoperative days 1 to 7. Assessment using propensity score matching showed that in hospital mortality was significantly lower in the high‐amino acid group (4.2% vs. 5.4%, p = 0.045). 4 Taken together, our findings may support that postoperative prescribed amino acid doses and the nonprotein energy‐to‐amino acid balance may influence clinical outcomes. However, these analyses did not adequately account for the nonprotein energy‐to‐amino acid balance as proposed by Shen et al. Therefore, further investigation of the impact of the nonprotein energy‐to‐amino acid balance on clinical outcomes is a critically important next step toward refining parenteral nutrition management in patients after gastrointestinal cancer surgery. CONFLICT OF INTEREST STATEMENT Y. Kawaguchi received adviser and lecture fees from Otsuka Pharmaceutical Factory, Inc. K. Murotani received adviser fees from Otsuka Pharmaceutical Factory, Inc. N. Hayashi and S. Kamoshita were employed by Otsuka Pharmaceutical Factory, Inc. FUNDING This study received no funding, and it was conducted by Otsuka Pharmaceutical Factory, Inc. REFERENCES